Bleeding patterns in women using intramuscular progesterone for luteal support in in-vitro fertilisation cycles

References

• Araujo E. Jr, Bernardini L., Frederick J.L., Asch R.H. and Balmaceda J.P. (1994) Prospective randomized comparison of human chrionic gonadotrophin versus intramuscular progesterone for luteal phase support in assisted reproduc-tion. Journal of Assisted Reproduction and Genetics, 11, 74–78.
   PubMed Web of Science ®Google Scholar
• Artini P.G., Volpe A., Angioni S., Galassi MC., Battaglia C. and Genazzani A.R. (1995) A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program. Journal of Endocrinolo-gical Investigation, 18, 51–56.
   PubMed Web of Science ®Google Scholar
• Bourgain C., Devroey P., Van Waesberghe L., Smitz J. and Van Steirteghem A.C. (1990) Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Human Reproduction, 5, 537–543.
   PubMed Web of Science ®Google Scholar
• Csapo AL., Pulkkinen M.O., Ruttner B., Sauvage J.P. and Wlest W.G. (1972) The significance of human corpus luteum in pregnancy maintenance. American Journal of Obstetrics and Gynecology, 112, 1061–1063.
   PubMed Web of Science ®Google Scholar
• Devroey P., Palermo G., Bourgain C., Van Waesberghe L., Smitz J. and Van Steirteghem A.C. (1989) Progesterone administration in patients with absent ovaries. International Journal of Fertility, 34, 188–193.
   PubMedGoogle Scholar
• Ginsburg K.A. (1992) Luteal phase defect. Etiology, diagnosis and management. Endocrinology and Metabolism Clinics of North America, 21, 85–104.
   PubMed Web of Science ®Google Scholar
• Johansson E.D.B. (1972) Plasma levels of progesterone achieved by different routes of administration. Acta Obstetricia et Gynecologica Scandinavica, 19 (Supplement), 17–20.
   Google Scholar
• Jones G.S. (1991) Luteal phase defect: a review of pathophy-siology. Current Opinion in Obstetrics and Gynecology, 3, 641–648.
   Google Scholar
• Jordan J., Craig K., Clifton D.K. and Soules M.R. (1994) Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertility and Sterility, 62, 54–62.
   Google Scholar
• Miles R.A., Paulson R.J., Lobo R.A., Press M.F., Dahmoush L. and Sauer M.V. (1994) Pharmacokinetics and endometrial tissue levels of progesterone after administration by intra- muscular and vaginal routes: a comparative study. Fertility and Sterility, 62, 485–490.
   PubMed Web of Science ®Google Scholar
• Nillius S.J. and Johansson E.D.B. (1971) Plasma levels of progesterone after vaginal, rectal or intramuscular administration of progesterone. American Journal of Obstetrics and Gynecology, 110, 470–477.
   PubMed Web of Science ®Google Scholar
• Roman E., Aytoz A., Smitz J.E.J., Faguer B., Camus M., Van Steirteghem A.C. and Devroey P. (2000) Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized proges-terone. Human Reproduction, 7,1435–1439.
   Google Scholar
• Simon J., Robinson D., Andrews M., Hildebrand J.R., Rocci ML., Blake R.E. and Hodgen G.D. (1993) The absorption of oral micronized progesterone: the effects of food, dose proportionality and comparison with intramuscular proges-terone. Fertility and Sterility, 60, 26–33.
   Google Scholar
• Soliman S., Daya S., Collins J. and Hughes E.G. (1994) The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertility and Sterility, 61, 1068–1076.
   PubMed Web of Science ®Google Scholar
• Smitz J., Devroey P., Camus M., Deschacht J., Khan I., Staessen O., Von Waesberghe L., Wisanto A. and Van Steirteghem A.C. (1985) The luteal phase and early preg-nancy after combined GnRH-agonist—HMG treatment for superovulation in IVF or GIFT. Human Reproduction, 3, 585–590.
   Google Scholar
• Smitz J., Devroey P., Faguer B., Bourgain C., Camus M., Van Steirteghem A.C. (1992) A prospective randomized compar-ison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Human Reproduction, 7,168–175.
   PubMed Web of Science ®Google Scholar
• Steege J., Rupp S., Stout A., and Bernhisel M. (1986) Bioavailability of nasally administered progesterone. Fertility and Sterility, 46, 727–729.
   PubMed Web of Science ®Google Scholar
• Stovall D., Van Voorhis B., Mattingly K., Sparks A.E., Chapler F.K. and Syrop C.H. (1996) The effectiveness of sublingual progesterone administration during cryopre-served embryo transfer cycles: results of a matched follow-up study. Fertility and Sterility, 65, 986–991.
   PubMed Web of Science ®Google Scholar
• Villanueva B., Casper R.F. and Yen S.S.C. (1981) Intravaginal administration of progesterone: enhanced absorption after estrogen treatment. Fertility and Sterility, 35, 433–437.
   PubMed Web of Science ®Google Scholar